1 If confirmed, the finding could eventually allow physicians to optimize GLP-1 dosing strategies with cardiovascular outcomes in mind, distinct from weight management goals
It can be expensive, and insurance coverage may vary
You can also contact our support team who will do this for you
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily prescribed for type 2 diabetes management and, more recently, for weight management in adults with obesity or overweight with weight-related comorbidities
Jalleh RJ, Plummer MP, Marathe CS, Umapathysivam MM, Quast DR, Rayner CK, Jones KL, Wu T, Horowitz M, Nauck MA (2024) Clinical consequences of delayed gastric emptying with GLP-1 receptor agonists and tirzepatide
Lloberas J, Muoz JP, Hernndez-lvarez MI, Cardona PJ, Zorzano A, Celada A